Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Bicycle Therapeutics has reported Receivables - Net for 7 years, with the latest figure at $136000.0 in Q1 2025.

• For the quarter ending Q1 2025, Receivables - Net changed N/A year-over-year to $136000.0; the trailing twelve-month figure through Mar 2025 stood at $136000.0 (changed N/A YoY), and the FY2022 full-year result was $2.0 million, up 104.5% from the prior year.
• Receivables - Net for Q1 2025 stood at $136000.0, down from $233000.0 in the prior quarter.
• The five-year high for Receivables - Net was $50.0 million in Q1 2023, with the low at $136000.0 in Q1 2025.
• Historically, Receivables - Net has averaged $12.5 million across 5 years, with a median of $2.0 million in 2022.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 2073.91% — and 2024, when it sank 99.48%.
• Bicycle Therapeutics' Receivables - Net stood at $1.0 million in 2021, then jumped by 104.5% to $2.0 million in 2022, then surged by 2104.89% to $45.1 million in 2023, then slumped by 99.48% to $233000.0 in 2024, then tumbled by 41.63% to $136000.0 in 2025.
• The last three Receivables - Net figures came in at $136000.0 (Q1 2025), $233000.0 (Q2 2024), and $45.1 million (Q2 2023), per Business Quant data.